To validate NF2 as a driver of MEK inhibitor resistance and elucidate functional consequences of combined NF1 and NF2 loss in Schwann cell tumors, NF2 was suppressed in NF1-mutant NF95.11b neurofibroma cells using CRISPRi. This evidence concerns the gene NF2 and plexiform neurofibroma.